These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21056825)

  • 1. No tolerance to rocuronium-induced neuromuscular blockade in a patient with prolonged testosterone therapy.
    Mizogami M; Mukozawa M; Kohno T; Takakura K
    J Clin Anesth; 2010 Nov; 22(7):579-80. PubMed ID: 21056825
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.
    Gilliard V; Delvaux B; Russell K; Dubois PE
    Acta Anaesthesiol Belg; 2006; 57(2):157-9. PubMed ID: 16916186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 5. The optimal dose of rocuronium for rapid sequence induction.
    El-Orbany M; Antapli M
    Can J Anaesth; 2009 Nov; 56(11):871. PubMed ID: 19779954
    [No Abstract]   [Full Text] [Related]  

  • 6. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
    Kocabas S; Yedicocuklu D; Askar FZ
    Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming rapacuronium: a comparison with rocuronium and mivacurium.
    Steinberg D
    Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged closed-loop control of muscle relaxation using rocuronium.
    De Haes A; Eleveld DJ; Wierda JM
    Anaesthesia; 2002 Dec; 57(12):1237-8. PubMed ID: 12437752
    [No Abstract]   [Full Text] [Related]  

  • 10. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 11. Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis muscles.
    Suzuki T; Mizutani H; Miyake E; Fukano N; Saeki S; Ogawa S
    Acta Anaesthesiol Scand; 2009 Nov; 53(10):1336-40. PubMed ID: 19650798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed reversal of a potentiated rocuronium neuromuscular block.
    Dubois PE
    Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful use of rocuronium and sugammadex in a patient with myasthenia.
    Petrun AM; Mekis D; Kamenik M
    Eur J Anaesthesiol; 2010 Oct; 27(10):917-8. PubMed ID: 20375901
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Pulz S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Nov; 51(11-12):655. PubMed ID: 27884025
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of rocuronium for ophthalmological surgery in an alpaca.
    Yamaoka TT; Auckburally A
    Vet Anaesth Analg; 2015 Nov; 42(6):657-8. PubMed ID: 26284691
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex.
    Drobnik L; Sparr HJ; Thörn SE; Khuenl-Brady KS; Rietbergen H; Prins ME; Ullman J
    Eur J Anaesthesiol; 2010 Oct; 27(10):866-73. PubMed ID: 20523215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.